HRT Financial’s Haemonetics HAE Stock Holding History

HRT Financial’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.9M	Buy	193,634 +77,766	+67%	+$5.06M	0.03%	590
2025 Q4	$9.29M	Buy	115,868 +80,238	+225%	+$5.39M	0.03%	488
2025 Q3	$1.74M	Buy	+35,630	New	+$2.21M	0.01%	1219
2025 Q2	–	Sell	-17,931	Closed	-$1.14M	–	2994
2025 Q1	$1.14M	Buy	+17,931	New	+$1.22M	0.01%	1069
2023 Q1	–	Sell	-43,145	Closed	-$3.39M	–	2755
2022 Q4	$3.39M	Buy	+43,145	New	+$3.47M	0.05%	381
2022 Q3	–	Sell	-55,878	Closed	-$3.64M	–	3079
2022 Q2	$3.64M	Buy	+55,878	New	+$3.31M	0.04%	342
2022 Q1	–	Sell	-11,197	Closed	-$593K	–	3390
2021 Q4	$593K	Buy	+11,197	New	+$682K	﹤0.01%	1626
2021 Q2	–	Sell	-16,485	Closed	-$1.83M	–	3114
2021 Q1	$1.83M	Buy	+16,485	New	+$2.04M	0.02%	668
2020 Q3	–	Sell	-37,989	Closed	-$3.4M	–	2074
2020 Q2	$3.4M	Buy	+37,989	New	+$3.84M	0.1%	202
2020 Q1	–	Sell	-10,342	Closed	-$1.19M	–	989
2019 Q4	$1.19M	Sell	10,342 -1,060	-9%	-$128K	0.05%	286
2019 Q3	$1.44M	Buy	+11,402	New	+$1.45M	0.07%	254
2019 Q2	–	Sell	-8,408	Closed	-$735K	–	814
2019 Q1	$735K	Buy	+8,408	New	+$765K	0.11%	127

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HRT Financial's HAE Position: Q1 2026 in Review

HRT Financial increased its Haemonetics (HAE) stake by 67% in Q1 2026, buying an estimated $5.06M and bringing the position to 193,634 shares worth $10.9M. The position accounts for 0.03% of the portfolio, ranked #590.

HRT Financial first reported a position in HAE in Q1 2019 and has held it in 12 quarters since. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

HRT Financial held 193,634 shares of Haemonetics worth $10.9M as of Q1 2026.
HRT Financial bought 77,766 Haemonetics shares in Q1 2026, an estimated $5.06M.
Haemonetics made up 0.03% of HRT Financial's portfolio in Q1 2026, its #590 holding.
HRT Financial first reported a position in Haemonetics in Q1 2019 and has held it in 12 quarters since.
324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.